Please login to the form below
Caudex Medical makes senior hires
Appoints Andy Bowman and Gary Burd
Caudex Medical has appointed Andy Bowman as its new global head and Gary Burd as director of scientific services.
Bowman joins the Oxford, UK-based medical education agency from the Choice Group where he was CEO of Choice Healthcare Solutions and, latterly, vice chairman of the Choice Group.
Initially qualifying as a microbiologist, Bowman moved into pharmaceutical sales and then training. He now has over 20 years' pharmaceutical company and agency experience on global and local stages.
Andy Bowman and Gary Burd
Meanwhile, Gary Burd joins Caudex Medical from Complete HealthVizion, where he worked for five years, initially as an editorial team leader and then a scientific director. Prior to this Gary spent three years as an editorial projects manager at Parexel.
Share
Related Hub content
COVID-19 Updates and Daily News
Featured jobs
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
-
Account Manager
-
£Competitive Salary
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
-
Account Manager (PR)
-
Great Benefits
-
Senior External Communications Lead
-
£Competitive Salary
-
Account Director
-
£Competitive Salary
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
- Sanofi doses first patient in global Kevzara COVID-19 trial
- Moderna chairman says COVID-19 vaccine could begin phase 2 trials in spring
- MHRA raises concerns over fraudulent coronavirus tests
- Moderna chairman says COVID-19 vaccine could begin phase 2 trials in spring
- Clinical trial of Gilead’s coronavirus hopeful remdesivir begins in UK
- Novartis donates malaria drug for COVID-19 clinical trials
- Servier agrees to buy Symphogen to swell its cancer pipeline
- A Renewed Love of the NHS and National Recovery of the Patient-Doctor Relationship
- GSK and Vir Biotech join forces for COVID-19 antibodies
- Coronavirus causes Cancer Research UK to slash funding by £44m
- EMA backs compassionate use of Gilead’s remdesivir for COVID-19
- Nurses on the frontline – World Health Day 2020
PMHub
An agency called Owen
We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....
Latest intelligence
- What challenges still face clinical trial recruitment and retention?
- Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
- “Fake News” and Credibility in Medical Publishing
- Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
- Delivering true value: what does it mean for KAM in cancer care?
- Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Quick links
Infographics
